Clinical evaluation of haloperidol in geriatric patients. 1970

J M Tobin, and E R Brousseau, and A A Lorenz

UI MeSH Term Description Entries
D011596 Psychomotor Disorders Abnormalities of motor function that are associated with organic and non-organic cognitive disorders. Psychomotor Impairment,Developmental Psychomotor Disorders,Psychomotor Disorders, Developmental,Developmental Psychomotor Disorder,Impairment, Psychomotor,Impairments, Psychomotor,Psychomotor Disorder, Developmental,Psychomotor Impairments
D011600 Psychopharmacology The study of the effects of drugs on mental and behavioral activity.
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J M Tobin, and E R Brousseau, and A A Lorenz
February 1967, Nederlands tijdschrift voor geneeskunde,
J M Tobin, and E R Brousseau, and A A Lorenz
January 1980, International pharmacopsychiatry,
J M Tobin, and E R Brousseau, and A A Lorenz
April 1982, Acta psychiatrica Scandinavica,
J M Tobin, and E R Brousseau, and A A Lorenz
May 1967, Current therapeutic research, clinical and experimental,
J M Tobin, and E R Brousseau, and A A Lorenz
January 1996, Neuropsychobiology,
J M Tobin, and E R Brousseau, and A A Lorenz
November 1979, The Journal of clinical psychiatry,
J M Tobin, and E R Brousseau, and A A Lorenz
June 1980, The Journal of clinical psychiatry,
J M Tobin, and E R Brousseau, and A A Lorenz
June 1966, Geriatrics,
J M Tobin, and E R Brousseau, and A A Lorenz
January 1968, Orvosi hetilap,
J M Tobin, and E R Brousseau, and A A Lorenz
January 1988, Public health reports (Washington, D.C. : 1974),
Copied contents to your clipboard!